Table of Contents
• Mucopolysaccharidosis overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Mucopolysaccharidosis Market
• Global Epidemiology of Mucopolysaccharidosis Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Mucopolysaccharidosis Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Mucopolysaccharidosis (2013-2023)
• Table 7: Mucopolysaccharidosis Global Market (USD Millions), (2013-2015)
• Table 8: Mucopolysaccharidosis Global Market (USD Millions), (2016-2023)
• Table 9: Mucopolysaccharidosis US Market (USD Millions), (2013-2015)
• Table 10: Mucopolysaccharidosis US Market (USD Millions), (2016-2023)
• Table 11: Mucopolysaccharidosis Germany Market (USD Millions), (2013-2015)
• Table 12: Mucopolysaccharidosis Germany Market (USD Millions), (2016-2023)
• Table 13: Mucopolysaccharidosis United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Mucopolysaccharidosis United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Mucopolysaccharidosis France Market (USD Millions), (2013-2015)
• Table 16: Mucopolysaccharidosis France Market (USD Millions), (2016-2023)
• Table 17: Mucopolysaccharidosis Italy Market (USD Millions), (2013-2015)
• Table 18: Mucopolysaccharidosis Italy Market (USD Millions), (2016-2023)
• Table 19: Mucopolysaccharidosis Spain Market (USD Millions), (2013-2015)
• Table 20: Mucopolysaccharidosis Spain Market (USD Millions), (2016-2023)
• Table 21: Mucopolysaccharidosis Japan Market (USD Millions), (2013-2015)
• Table 22: Mucopolysaccharidosis Japan Market (USD Millions), (2016-2023)
• Table 23: Mucopolysaccharidosis ROW Market (USD Millions), (2013-2015)
• Table 24: Mucopolysaccharidosis ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Mucopolysaccharidosis Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Mucopolysaccharidosis (2013-2023)
• Figure 3: Mucopolysaccharidosis Global Market (USD Millions), (2013-2015)
• Figure 4: Mucopolysaccharidosis Global Market (USD Millions), (2016-2023)
• Figure 5: Mucopolysaccharidosis US Market (USD Millions), (2013-2015)
• Figure 6: Mucopolysaccharidosis US Market (USD Millions), (2016-2023)
• Figure 7: Mucopolysaccharidosis Germany Market (USD Millions), (2013-2015)
• Figure 8: Mucopolysaccharidosis Germany Market (USD Millions), (2016-2023)
• Figure 9: Mucopolysaccharidosis United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Mucopolysaccharidosis United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Mucopolysaccharidosis France Market (USD Millions), (2013-2015)
• Figure 12: Mucopolysaccharidosis France Market (USD Millions), (2016-2023)
• Figure 13: Mucopolysaccharidosis Italy Market (USD Millions), (2013-2015)
• Figure 14: Mucopolysaccharidosis Italy Market (USD Millions), (2016-2023)
• Figure 15: Mucopolysaccharidosis Spain Market (USD Millions), (2013-2015)
• Figure 16: Mucopolysaccharidosis Spain Market (USD Millions), (2016-2023)
• Figure 17: Mucopolysaccharidosis Japan Market (USD Millions), (2013-2015)
• Figure 18: Mucopolysaccharidosis Japan Market (USD Millions), (2015-2023)
• Figure 19: Mucopolysaccharidosis ROW Market (USD Millions), (2013-2015)
• Figure 20: Mucopolysaccharidosis ROW Market (USD Millions), (2016-2023)
【掲載企業】
• Sanofi
• BioMarin Pharmaceutical Inc.
• BioMarin/Genzyme LLC
• ArmaGen,Inc.
• Sangamo BioSciences Inc.
• PTC Therapeutics Inc.
• Nuo Therapeutics Inc.
• ldagen Inc.
• Fate Therapeutics Inc.
• Celgene Corporation
【レポートのキーワード】
ムコ多糖症
【免責事項】
https://www.marketreport.jp/reports-disclaimer